Andrew McLaughlin

Global Business Intelligence Lead, Director at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Andrew McLaughlin's Colleagues at Alnylam Pharmaceuticals
Kristen Dvorscak

Director, Global Quality Systems

Contact Kristen Dvorscak

Nicole Gullotti

Clinical Trial Specialist

Contact Nicole Gullotti

Allison Callahan

Associate Director, Quality Assurance

Contact Allison Callahan

Amy Hansen

Associate Director Quality Assurance

Contact Amy Hansen

Catherine Summers

Assoc. Global Medical Director - TTR Amyloidosis

Contact Catherine Summers

Renata Porto

Business Account Executive hTTR and AHP

Contact Renata Porto

View All Andrew McLaughlin's Colleagues
Andrew McLaughlin's Contact Details
HQ
(617) 551-8200
Location
Reading,Pennsylvania,United States
Company
Alnylam Pharmaceuticals
Andrew McLaughlin's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Andrew McLaughlin
Andrew McLaughlin currently works for Alnylam Pharmaceuticals.
Andrew McLaughlin's role at Alnylam Pharmaceuticals is Global Business Intelligence Lead, Director.
Andrew McLaughlin's email address is ***@alnylam.com. To view Andrew McLaughlin's full email address, please signup to ConnectPlex.
Andrew McLaughlin works in the SaaS industry.
Andrew McLaughlin's colleagues at Alnylam Pharmaceuticals are Kristen Dvorscak, Nicole Gullotti, Jennifer Harpalani, Allison Callahan, Amy Hansen, Catherine Summers, Renata Porto and others.
Andrew McLaughlin's phone number is (617) 551-8200
See more information about Andrew McLaughlin